buyWeak
STEINER EDDIE L bought $24k of CSBB
President & CEO at CSB Bancorp, Inc.. 623 shares at an average of $38.35, traded Dec 23, 2024, filed Dec 26, 2024.
Conviction score
30Value
$24k
623 shares
Holdings after
39,850
+3% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000950170-24-140011, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 23, 2024 | POpen-market purchase Common Stock | +125 | $38.50 | $4,813 | 22,242 | Dec 26, 2024 |
| Dec 23, 2024 | POpen-market purchase Common Stockindirect: IRA | +98 | $38.30 | $3,753 | 39,450 | Dec 26, 2024 |
| Dec 23, 2024 | POpen-market purchase Common Stockindirect: IRA | +400 | $38.31 | $15k | 39,850 | Dec 26, 2024 |
Related signals
Other insiders at CSB Bancorp, Inc. and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 41Moderate | buy | CSBB CSB Bancorp, Inc. | STEINER EDDIE L President & CEO | $77k | 2,000 | |
| 25Weak | buy | CSBB CSB Bancorp, Inc. | STEINER EDDIE L President & CEO | $7,169 | 185 | |
| 40Moderate | buy | CSBB CSB Bancorp, Inc. | STEINER EDDIE L President & CEO | $58k | 1,500 | |
| 30Weak | buy 3 | CSBB CSB Bancorp, Inc. | BAKER ROBERT K director | $23k | 600 | |
| 30Weak | buy 4 | CSBB CSB Bancorp, Inc. | Coblentz Julian L director | $7,700 | 200 | |
| 36Weak | buy 4 | CSBB CSB Bancorp, Inc. | Kirkbride Cheryl M director | $9,628 | 250 | |
| 40Moderate | buy 3 | CSBB CSB Bancorp, Inc. | STEINER EDDIE L President & CEO | $23k | 600 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.